All Government articles – Page 34
-
BusinessBiggest venture yet of any pharma company into cannabis
Jazz Pharmaceuticals buys cannabinoid therapeutic firm for $7.2 billion, inheriting first plant-derived cannabinoid medicine ever approved by FDA
-
BusinessCovid vaccination efforts bolstered by trial results from J&J and Novavax
A miserable January ended with positive news on the vaccine front but new variants added complications
-
NewsWellcome Leap launches global network to tackle pressing health issues
More than 20 research institutions are part of new effort to the cut red tape hindering research
-
OpinionObserving the state’s transition
Sweeping changes on both sides of the Atlantic have yet to deliver on their promises
-
BusinessPatent applications listing AI as an inventor run into legal problems
Artificial intelligence is increasingly being used to find new chemical compounds and repurpose drugs, but should laws be updated to protect the intellectual property of such discoveries?
-
News£10m to help specialist UK research institutions hit by charity shortfall
Research England funds will support research on cancer and tropical diseases
-
NewsMIT faculty rally around colleague arrested for Chinese government links
Letter to university’s president signed by 170 faculty members debunks charges against nanotechnologist Gang Chen
-
OpinionA Brexit deal has been reached – will it work for UK science?
Researchers must now make the best of the Brexit agreement
-
NewsBiden thrills US research community with his science ‘dream team’
The new US president has elevated the role of science in the White House
-
NewsMIT nanotechnologist arrested for hiding his ties to China
The head of an MIT nanoengineering lab who worked at the university for decades is accused of grant fraud and faces up to 30 years in jail
-
BusinessVaccine approvals offer hope as global Covid cases surge
A handful of vaccines are now approved and the first doses are being given to patients, with trials for many more candidates nearing completion
-
NewsWhat does the Brexit deal mean for research and industry?
Relief, disappointment, questions and concerns
-
NewsBrexit deal creates path for UK science to engage with EU but ambiguity remains
UK embarking on era of pay-to-play in EU research programmes
-
BusinessIndustry expects problems ahead after initial relief over Brexit deal
Uncertainty still looms over regulation and logistics
-
NewsMassachusetts crime lab scandal could widen as another chemist is investigated
A third Massachusetts state chemist is being investigated for possible misconduct that might have resulted in wrongful convictions
-
BusinessChaos on Capitol Hill prompts changes in pharma and biotech
Dow won’t donate to lawmakers who refused to certify presidential votes, others like 3M, Amgen, BIO and PhRMA pause political giving to reassess
-
NewsGovernment to review gene-editing regulations for animals and crops in England
Consultation seeks public’s view on genetically-modified organisms produced using tools such as Crispr
-
OpinionClimate action plans will point to methane metrics in 2021
It’s good to see policymakers and companies making methane emissions data a priority
-
BusinessChemicals industry roundup 2020
Pandemic provides impetus to re-tune supply chains for resilience and sustainability
-
BusinessPharmaceuticals roundup 2020
Alongside the race for Covid-19 treatments and vaccines, the industry has maintained momentum